<DOC>
	<DOCNO>NCT00135408</DOCNO>
	<brief_summary>The purpose study determine Efficacy , Safety Tolerability MDX-010 ( BMS-734016 ) administer without Prophylactic Oral Budesonide .</brief_summary>
	<brief_title>A Study MDX-010 ( BMS-734016 ) Administered With Without Prophylactic Oral Budesonide</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Histologic cytologic diagnosis unresectable Stage III IV malignant melanoma ( exclude ocular melanoma ) Flexible Sigmoidoscopy colonic biopsy require Patients active , untreated central nervous system metastasis . Patients autoimmune disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Unresectable Stage III IV Malignant Melanoma</keyword>
</DOC>